Clinical aspects of diabetes secondary to idiopathic haemochromatosis in French-speaking Belgium;Aspects cliniques du diabete secondaire a l'hemochromatose idiopathique en belgique francophone

Diabetes and Metabolism

Volumn 23, Issue 4, 1997, Pages 308-313

  Buysschaert, M ^a   Paris, I ^a   Selvais, Ph ^b   Hermans, M P ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Cirrhosis; Diabetes; Haemochromatosis; Treatment

Indexed keywords

DEFEROXAMINE; INSULIN;

ADULT; ARTICLE; BELGIUM; DIABETES MELLITUS; EARLY DIAGNOSIS; FEMALE; HEMOCHROMATOSIS; HUMAN; HYPERGLYCEMIA; IDIOPATHIC DISEASE; INSULIN TREATMENT; IRON OVERLOAD; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PHLEBOTOMY;

ADULT; AGED; BELGIUM; DIABETES COMPLICATIONS; FEMALE; GLUCOSE TOLERANCE TEST; HEMOCHROMATOSIS; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RURAL HEALTH; URBAN HEALTH;

EID: 0030800536     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Simon M, Bourel M, Genetet B, Fauchet R. Idiopathic hemochromatosis. Demonstration of recessive inheritance and early detection by HLA typing. N Engl J Med, 1977, 297, 1017-1021.
2. Simon M, Fauchet R, Hespel JP et al. Idiopathic hemochromatosis : a study of biochemical expression in 247 heterozygous members of 63 families : evidence for a single major HLA-linked gene. Gastroenterology, 1980, 78, 703-708.
3. Feder JN, Gnirke A, Thomas W et al. A novel MHC class-I like gene is mutated in patients with hereditary haemochromatosis. Nature Genet, 1996, 13, 399-408.
4. Niederau C, Strohmeyer G, Stremmel W. Epidemiology, clinical spectrum and prognosis of hemochromatosis. Adv Exp Med Biol, 1994, 356, 293-302.
5. Simon M. Disorders of iron metabolism and related disorders. In : Principles and practice of medical genetics. 2nd ed. Emery AE, Rimoin DL, Eds. Edinburgh, London, Melbourne, New York, Churchill Livingstone, 1990, 1783-1796.
6. Adams P, Kertesz A, Valberg L. Clinical presentation of hemochromatosis : a changing scene. Am J Med, 1991, 90, 445-449.
7. Trousseau A. Clinique médicale de l'Hôtel-Dieu de Paris, 1865, 2, 663-698.
8. Edwards CQ, Cartwright G, Sknolnick M, Amos D. Homozygosity for hemochromatosis : clinical manifestations. Ann Int Med, 1980, 93, 519-525.
9. Stocks AE, Powell L. Carbohydrate intolerance in idiopathic hemochromatosis and cirrhosis of the liver. Q J Med, 1973, 42, 733-749.
10. Niederau C, Fisher R, Sonnenberg A, Stremmel W, Trampisch H, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med, 1985, 313, 1256-1262.
11. Adams P, Speechley M, Kertesz A. Long-term survival analysis in hereditary hemochromatosis. Gastroenterology, 1991, 101, 368-372.
12. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes, 1983,24, 100-106.
13. Balan V, Baldus W, Fairbanks V, Michels V, Burritt M, Klee G. Screening for hemochromatosis : a cost-effectiveness study based on 12,558 patients. Gastroenterologe, 1994, 107, 453-459.
14. Simon M, Lemignon L, Edan G, Lereun M, Hespel JP. Diabètes « d'autres types »: pancréatite chronique et hémochromatose. In: Journées Annuelles de Diabétologie. Hôtel-Dieu, Flammarion, Paris, 1984,85-114.
15. Milman N. Hereditary haemochromatosis in Denmark 1950-1985. Clinical, biochemical and histological features in 179 patients and 13 preclinical cases. Dan Med Bull, 1991, 38, 85-393.
16. Yaouanq JM, Poirier JY, Maugendre D, Brissot P, Allanic H. Genetic hemochromatosis and diabetes : a study in 474 hemochromatosic patients (Abstract). Diabetologia, 1993, 33 (suppl.), A186.
17. Phelps G, Chapman I, Hall P, Braund W, Mackinnon M. Prevalence of genetic haemochromatosis among diabetic patients. Lancet, 1989, 11, 233-234.
18. Czink E, Tamas G. Screening for idiopathic hemochromatosis among diabetic patients. Diabetes Care, 1991, 14, 929.
19. George D, Evans R, Crofton R, Gunn I. Testing for haemochromatosis in the diabetic clinic. Ann Clin Biochem, 1995, 32, 521-526.
20. Rahier J, Loozen S, Goebbels RM, Abrahem M. The haemochromatic human pancreas : a quantitative immunohistochemical and ultrastructural study. Diabetologia, 1987, 30, 5-12.
21. Awai M, Narasaki M, Yamanoi Y, Seno S. Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate. Am J Path, 1979, 95, 663-674.
22. 3 + -NTA. An ultrastructural study of diabetic rats. Acta Pathol Jpn, 1989, 39, 154-168.
23. Schafer A, Cheron R, Dluhy R et al. Clinical consequences of acquired transfusional iron overload in adults. N Engl J Med, 1981, 304, 319-324.
24. Niederau C, Berger M, Stremmel W et al. Hyperinsulinemia in non-cirrhotic haemochromatosis : impaired hepatic insulin degradation ? Diabetologia, 1984, 26, 441-444.
25. Kruszynska Y, Harry D, Bergman R, McIntyre N. Insulin sensitivity, insulin secretion and glucose effectiveness in diabetic and nondiabetic cirrhotic patients. Diabetologia, 1993, 36, 121-128.
26. Petrides A, Vogt C, Schulze-Berge D, Matthews D, Strohmeyer G. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology, 1994, 19, 616-627.
27. Dmochowski K, Finegood D, Francombe W, Tyler B, Zinman B. Factors determining glucose tolerance in patients with thalassemia major. J Clin Endocrinol Metab, 1993, 77, 478-483.
28. Yaouanq JM. Diabetes and haemochromatosis : current concepts, management and prevention. Diabète et Métabolisme (Paris), 1995, 21, 319-329.
29. Griffith JD, Dymock IW, Davies E, Hill D, Williams R. Occurrence and prevalence of diabetic retinopathy in hemochromatosis. Diabetes, 1971, 20, 766-770.
30. Hermans MP, Maes M, Vandeleene B, Pirard F et Buysschaert M. The Belgian health service HBGM scheme : cost-effectiveness in a cross-sectional survey of an insulin-treated population registry. 10th International Congress of Endocrinology, San Francisco, CA, USA, June 1996, Abstract P3-1066 :1021.
31. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993, 329, 977-986.
32. Buysschaert M, Paris I, Magnan A, Donckier J, Hermans MP. Prevalence and clinical correlates of endocrine complications in cirrhotic and non-cirrhotic subjects with idiopathic haemochromatosis. 10th International Congress of Endocrinology ; San Francisco, CA, USA, June 1996, Abstract P1-801 :335.